Skip to main content
. 2015 Jun 24;3(5):1088–1092. doi: 10.3892/mco.2015.584

Figure 1.

Figure 1.

Comparative analysis between prechemotherapy and controls of (A) D-dimer, (B) activated partial thromboplastin time (APTT), (C) prothrombin time (PT) and (D) fibrinogen (FIB). The value of D-dimer was significantly different between prechemotherapy and control (P<0.05), while APTT, PT and FIB were not altered in breast cancer patients compared to the controls prior to chemotherapy (P>0.05).